Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells Activity

Full-text?

The full document isn't yet available to us from the patent office.

Abstract

The invention relates to antibodies against human CD39 and use thereof for inhibiting T regulatory cells (Treg) activity. More particularly CD39 antibodies may be used for the treatment or prevention of cancers and infectious diseases.


Claims

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Apr 12, 2017
  • Application: Jan 30, 2009
    EP EP 16198909 A
  • Priority: Jan 30, 2009
    EP EP 09705212 A
  • Priority: Aug 20, 2008
    EP EP 08162683 A
  • Priority: Jan 31, 2008
    EP EP 08300061 A

Download Citation


Sign in to the Lens

Feedback